Scienture (SCNX) Expected to Announce Earnings on Monday

Scienture (NASDAQ:SCNX) will likely be announcing its results after the market closes on Monday, May 11th. Analysts expect the company to announce earnings of ($0.23) per share and revenue of $0.4010 million for the quarter.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Monday, March 30th. The company reported ($1.76) EPS for the quarter, missing the consensus estimate of ($0.28) by ($1.48). The business had revenue of ($0.17) million during the quarter, compared to the consensus estimate of $0.49 million.

Scienture Trading Up 2.9%

SCNX traded up $0.01 during trading on Monday, hitting $0.41. The company’s stock had a trading volume of 41,459 shares, compared to its average volume of 2,581,061. Scienture has a twelve month low of $0.24 and a twelve month high of $2.60. The business’s fifty day simple moving average is $0.40 and its 200 day simple moving average is $0.53. The firm has a market capitalization of $16.78 million, a price-to-earnings ratio of -0.15 and a beta of 3.32.

Analyst Ratings Changes

Several analysts have commented on the company. Wall Street Zen raised Scienture to a “hold” rating in a report on Saturday, March 14th. Maxim Group started coverage on Scienture in a research report on Tuesday, February 24th. They set a “buy” rating and a $1.50 price objective on the stock. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research report on Friday, March 27th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1.50.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Scienture stock. Geode Capital Management LLC increased its stake in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) by 264.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 316,201 shares of the company’s stock after purchasing an additional 229,398 shares during the quarter. Geode Capital Management LLC owned 0.78% of Scienture worth $161,000 at the end of the most recent quarter. Institutional investors own 5.68% of the company’s stock.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.